van der stahl scientific. sterileaware™ podcast

On this episode of the SPOT™ Radio Podcast Charlie Webb CPPL speaks with Chris Danek CEO of Bessel about human-centered design and agile teamwork. Chris speaks on using advanced technology like artificial intelligence, additive manufacturing, and digital engineering and their support to medical device manufacturers.

Guest bio

Chris Danek, CEO of Bessel, is an entrepreneur and life sciences industry veteran. Chris believes in empowering technical teams. Trained in business and engineering, he has worked with dozens of teams in industry and at universities across the US. He helps them speed time-to-market with agile teamwork and human-centered design while using advanced technology like artificial intelligence, additive manufacturing, and digital engineering. Bessel clients and Powered by Bessel startups are located nationwide.

Chris is a visiting professor at the University of Texas at El Paso. This leading Hispanic-serving research university has adopted the Bessel Origin program in its Department of Aerospace and Mechanical Engineering. Chris is also a visiting professor at the W.M. Keck Center for 3D Innovation at UTEP.

Chris was co-founder and CEO of AtheroMed (now Philips AtheroMed), and before that was V.P. R&D of Asthmatx (Boston Scientific). Chris is an advisor to the Santa Clara University Healthcare Innovation and Design Lab. He has a Ph.D. in mechanical engineering from Stanford University and an M.B.A. with a concentration in finance from the Wharton School - University of Pennsylvania. He is an inventor of over 85 U.S. patents. 

About Bessel

Bessel's roots are in product lifecycle support for medical device and diagnostic products. With a foundation of more than 20 years of experience designing and developing medical devices, Chris Danek and Bessel have provided full-service support for over 5 years to diverse organizations ranging from startup companies to Fortune 50. We bring innovation throughout the product lifecycle -- from a clean sheet of paper through commercial release.

We combine human-centered design and agile teamwork (scrum) in our approach to work, with a dual focus on results and on improving the capabilities of our clients' teams.

Mentoring startup teams reminded me of my love of teaching. It was natural to step from putting the patient first as a medical device developer to putting the student first as a teacher. The core of the Bessel Origin program stems from my work helping students transform into excellent team members ready for the workforce.

My co-founder, Carolyn Danek, inspired the start of Bessel. Trained as an architect, Carolyn is professionally versed in human-centered design. Her deep-rooted empathy sparked the creation of Bessel. I'm fortunate to be her co-founder. ​

We saw the broad applicability of the Bessel Origin program and its mindsets, methods, and discipline to train the next generation of innovative thinkers and high-performance team members. Now we deliver corporate critical innovation projects and our Bessel Origin program.

Website: www.bessel.co 

On this episode of the SterileAware™ Podcast Charlie Webb CPPL speaks with Peter Hoff the Vice President of Sales at Nevoa. Peter speaks about their automated, no-touch, whole-room disinfection system designed for high-risk discharges that harness the power of hypochlorous acid.

Guest bio

Peter Hoff – Vice President of Sales at Nevoa. Peter has spent over 23 years in the healthcare and medical device industries helping customers improve patient outcomes.  He’s passionate about creating safer environments for patients and healthcare workers while reducing the environmental impact. 

About Nevoa
Nevoa was founded with a simple vision:  Use technology-based solutions to automate healthcare’s manual disinfection practices to reduce HAIs, improve patient outcomes, and save lives.

Despite incredible efforts taken by hospital teams across the county, HAIs continue to be a leading cause of death in the US. 

Harnessing the power of hypochlorous acid (HOCl), Nevoa’s No Touch technologies are helping transform the industry’s decades-old manual protocols to provide more consistent, effective, and efficient disinfecting solutions.

Nimbus is an Automated, No Touch, Whole Room disinfection system designed for high-risk discharges.  It’s the only patented, hospital-grade surface disinfecting system approved for fogging EPA-registered Hypochlorous Acid:

• Automatically Disinfects 100% of Room Surfaces
• Up to 99.9999% Effective Against HAI-causing pathogens
• pH Neutral and Gentle on Surfaces
• Nontoxic and Safe for Patients, Staff, and the Environment
• Allows Immediate Room Re-Entry

Stratus is a handheld fogger designed to rapidly disinfect targeted areas in the OR, ED, Dialysis, Outpatient Clinics, and Bulk Equipment.  The OR Between Case protocol allows you to significantly reduce the risk of SSIs in just 2 minutes.
 

Email:  peter.hoff@nevoainc.com

Website:  www.nevoainc.com

Linkedin:  www.linkedin.com/company/nevoa

On this episode of the SPOT™ Radio Podcast Charlie Webb CPPL speaks with Roy Morgan about new ways medical device manufacturers can streamline the process of sterilization and medical device packaging through Eagle Medical's PATH (packaging accelerated timeline help) program.

Guest bio

Roy Morgan is best known for his work in electrochemistry; the inventor of the world's first orthopedic device to upregulate genetic progenitor compounds in the healing process of osteoarthritis of the joints. His skills in R&D team building and fast-paced project execution, requiring FDA product acceptance are well known in the med-device community. Mr. Morgan possesses expert know-how in regulatory submission drafting, platform strategy, intellectual property, and project management.

Mr. Morgan is currently expanding Eagle's growth strategy; requiring new business methods for improving volume, speed-to-market and customer service. These are adjunct areas to which Mr. Morgan has consistently excelled having launched many medical devices with companies such as: Abbott Laboratories, Meditrina, and Stryker. Using his "advantage maker" leadership approach, he has brought to market episodic blood glucose meters; wireless continuous glucose monitoring systems; drug infusion pumps; and several electrosurgical systems.

His product design skills are highly sought after as are his engineering skills in both electromechanical-engineering and injection molding. Educated at Brown University, Providence, Rhode Island, Mr. Morgan gained a BSc. in Mechanical Engineering and a BA in Semiotics. At the University of California at Berkeley he became a Registered Professional Engineer and was awarded a Certificate in Project management. In 2000 Mr. Morgan was also awarded Project Management Professional designation from the Project Management Institute. At Eagle Medical, he leads with efficient and FDA compliant manufacturing, sterilization, packaging & packaging design service options for the medical device industry.

E-mail: info@eaglemed.com
Website: www.eaglemed.com
Phone: 1 (805) 238-7401

On this short episode of the Spot Radio Podcast Charlie Webb CPPL speaks about his visit to the HSPA (healthcare sterile processing association) conference in Nashville Tennessee.  Charlie also looks ahead to upcoming discussions on spot radio...

Host bio:

Charlie A. Webb CPPL | Founder & CEO of Van der Stähl Scientific

Charlie Webb CPPL is the founder and President of Van der Stahl Scientific; a medical device packaging and testing machine provider and packaging testing and calibration laboratories. He also hosts the popular Podcast "SPOT Radio" (sterile packaging on track) www.spotradiopodcast.com Charlie was recognized in the Rode Podcast awards as the top 100 ‘Highly Commended Podcast for his Podcast "Antidote to Despair" Charlie earned his BS degree in Management at University of Redlands and completed the medical device development program at the Andersen graduate school of management at UCLA. Charlie is a “lifetime” certified packaging professional “CPPL” certified through the institute of packaging professionals as well as a “Six Sigma Master Black Belt”. As a member of a scientific review board, he co-developed micro-surgical devices that broke away from the conservative innovation models. Charlie has been in sterile device packaging for 26 years and has been involved in numerous FDA and ISO audits as a regulatory advisor.

He is also a certified internal auditor and is the Quality Manager for Van der Stähl Scientific’s demanding ISO/IEC 17025 Laboratory accreditation. Under Charlie's quality management system his lab received the MSI Continuous Improvement Award. Charlie is a member of the IOPP Medical Device Packaging Technical Committee, he is a co-PM in the Kiip group and the ASTM F02 technical committee and has multiple granted and pending patents on medical device packaging machinery and pouch testing systems.

His current patent-pending technologies include a medical device tray sealer that will integrate pouch testing within the packaging machine to provide 100% real-time seal testing. Also, in development is his patented HTIP system (human tissue isolation pouch) this disposable system is designed to help avoid packaging machine contamination. His patented seal-through HTIP system isolates the donor tissue during packaging process to help thwart cross-contamination between donor events. This system will help prevent machine contamination and increases packaging machine component life cycles, saving money while managing infection risks to donor recipients.

His company was also recently awarded a federal contract as a medical device packaging machine provider for the VA Hospital group and his laboratory client list includes NASA and the CDC (center for disease control). He continues to grow his company’s new product development program with the aim of reaching more users of their equipment in order to better manage healthcare packaging failures.

E-mail:
Charlie@vanderstahl.com

Website:
www.vanderstahl.com
www.spotradiopodcast.com 

On this episode of  the SterileAware™ Podcast Charlie Webb CPPL speaks with Karen Goelst CEO of KleenEdge about their technology that helps manage patient curtain exchange cycles with the aim of preventing patient infections. 

Guest bio's:

Karen Goelst | Founder & CEO of KleenEdge 

With a 20-year background in architectural specialties and textiles, Karen Goelst became passionate about solving the issues surrounding privacy curtains following her 15-year-old son’s hospital stay with MRSA.

Staying at his bedside she noticed everybody touched the fabric privacy curtain, but the label showed that it hadn’t been exchanged for 14 months. Thankfully her son recovered, but this realization started her journey in trying to understand why curtains weren’t getting exchanged, when other touchpoints in the room were thoroughly disinfected.  Karen founded KleenEdge to ensure this infection risk did not impact other families.  

About KleenEdge

Launched in 2018, the company received early accolades for its innovative Protocol Compliance Software, receiving AHE’s Product Innovation Award, as well as getting patents for the QuickLoad and TeleTrack “no ladder” curtain exchange cubicle track solutions. KleenEdge’s solutions have helped many healthcare facilities dramatically reduce operational costs, while having peace of mind knowing that their curtain exchanges are compliant and deliver the highest standard of care for their patient’s safety.

KleenEdge builds its privacy curtain solutions on 4 pillars:

·      Protocol software that monitors curtain exchange compliance

·      Sustainable cost-saving recyclable curtains

·      No-ladder solutions to promote lean workflows and safety

·      Patient and staff safety

E-mail: kgoelst@KleenEdge.com

Website: www.kleenedge.com